|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/08/15 Angiodynamics Inc 10-Q 8/31/15 69:5.1M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 371K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
46: R1 Document and Entity Information HTML 41K
36: R2 Consolidated Statements of Income HTML 89K
44: R3 Consolidated Statements of Comprehensive Income HTML 50K
48: R4 Consolidated Balance Sheets HTML 127K
63: R5 Consolidated Balance Sheets (Parenthetical) HTML 47K
38: R6 Consolidated Statements of Cash Flows HTML 103K
43: R7 Consolidated Statement of Stockholders' Equity HTML 70K
32: R8 Consolidated Financial Statements HTML 30K
25: R9 Inventories HTML 32K
64: R10 Goodwill and Intangible Assets HTML 75K
50: R11 Accrued Liabilities HTML 38K
49: R12 Long Term Debt HTML 30K
54: R13 Income Taxes HTML 59K
55: R14 Share-Based Compensation HTML 30K
53: R15 Earnings Per Share HTML 33K
56: R16 Segment and Geographic Information HTML 49K
45: R17 Fair Value HTML 138K
47: R18 Marketable Securities HTML 53K
52: R19 Commitments and Contingencies HTML 35K
69: R20 Recently Issued Accounting Pronouncements HTML 32K
59: R21 Restructuring HTML 24K
40: R22 Inventories (Tables) HTML 31K
51: R23 Goodwill and Intangible Assets (Tables) HTML 70K
42: R24 Accrued Liabilities (Tables) HTML 37K
19: R25 Income Taxes (Tables) HTML 54K
60: R26 Earnings Per Share (Tables) HTML 31K
65: R27 Segment and Geographic Information (Tables) HTML 44K
28: R28 Fair Value (Tables) HTML 131K
27: R29 Marketable Securities (Tables) HTML 46K
30: R30 Consolidated Financial Statements - Additional HTML 70K
Information (Detail)
31: R31 Acquisitions - Additional Information (Detail) HTML 36K
33: R32 Inventories - Schedule of Inventories (Detail) HTML 30K
18: R33 Goodwill and Intangible Assets - Additional HTML 25K
Information (Detail)
57: R34 Goodwill and Intangible Assets - Goodwill by HTML 22K
Segment (Detail)
39: R35 Goodwill and Intangible Assets - Intangible Assets HTML 57K
(Detail)
41: R36 Accrued Liabilities - Summary of Accrued HTML 52K
Liabilities (Detail)
22: R37 Long Term Debt - Additional Information (Detail) HTML 77K
68: R38 Income Taxes - Components of Income Tax HTML 40K
Expense/(Benefit) (Detail)
12: R39 Income Taxes - Additional Information (Detail) HTML 31K
34: R40 Income Taxes Net Operating Loss Carryforwards HTML 45K
(Details)
62: R41 Share-Based Compensation (Details) HTML 29K
21: R42 Earnings Per Share - Reconciliation of Basic to HTML 28K
Diluted Weighted-Average Shares Outstanding
(Detail)
26: R43 Segment and Geographic Information - Additional HTML 22K
Information (Detail)
29: R44 Segment and Geographic Information - Summary of HTML 31K
Net Sales by Product Category (Detail)
37: R45 Segment and Geographic Information - Summary of HTML 31K
Net Sales by Geographic Area (Detail)
17: R46 Fair Value - Additional Information (Detail) HTML 21K
24: R47 Fair Value - Fair Value of Assets and Liabilities HTML 67K
Measured on a Recurring Basis (Detail)
14: R48 Fair Value - Fair Value Measurements Using HTML 41K
Significant Unobservable Inputs (Detail)
61: R49 Fair Value - Summary Showing the Recurring Fair HTML 53K
Value Measurements of the Contingent Consideration
Liability (Detail)
20: R50 Fair Value - Summary Showing Reconciliation of the HTML 25K
Contingent Payments (Detail)
58: R51 Marketable Securities - Additional Information HTML 23K
(Detail)
23: R52 Marketable Securities - Marketable Securities HTML 34K
(Detail)
35: R53 Commitments and Continfencies - Additional HTML 35K
Information (Detail)
13: R54 Restructuring - Additional Information (Detail) HTML 26K
16: R55 Immaterial Corrections (Details) HTML 111K
67: XML IDEA XML File -- Filing Summary XML 120K
15: EXCEL IDEA Workbook of Financial Reports XLSX 63K
6: EX-101.INS XBRL Instance -- ango-20150831 XML 1.26M
8: EX-101.CAL XBRL Calculations -- ango-20150831_cal XML 187K
9: EX-101.DEF XBRL Definitions -- ango-20150831_def XML 507K
10: EX-101.LAB XBRL Labels -- ango-20150831_lab XML 1.25M
11: EX-101.PRE XBRL Presentations -- ango-20150831_pre XML 786K
7: EX-101.SCH XBRL Schema -- ango-20150831 XSD 144K
66: ZIP XBRL Zipped Folder -- 0001275187-15-000022-xbrl Zip 167K
| Exhibit |
1. | I have reviewed this quarterly report on Form 10-Q of AngioDynamics, Inc.; | |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
4. | The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
(b) | Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
(d) | Disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |
5. | The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and
report financial information; and | |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/8/15 | 8-K | ||
| For Period end: | 8/31/15 | |||
| List all Filings | ||||